Moderna’s Coronavirus Vaccine Trial Could Offer Light At The End Of The Tunnel
PYMNTS
MAY 18, 2020
A COVID-19 vaccine being developed by the Cambridge, Massachusetts firm Moderna is showing early signs of promise, with an early-stage human trial showing some compelling results. According to reports, trial participants received an mRNA vaccine dose of 25, 100 or 250 micrograms, with 15 in each group. That’s because more than 4.7
Let's personalize your content